Download MendeleyDefective lytic transglycosylase disrupts cell morphogenesis by hindering cell wall de-O-acetylation inNeisseria meningitidis.
Williams, A.H., Wheeler, R., Deghmane, A.E., Santecchia, I., Schaub, R.E., Hicham, S., Moya Nilges, M., Malosse, C., Chamot-Rooke, J., Haouz, A., Dillard, J.P., Robins, W.P., Taha, M.K., Gomperts Boneca, I.(2020) Elife 9
- PubMed: 32022687
- DOI: https://doi.org/10.7554/eLife.51247
- Primary Citation of Related Structures:
6H5F - PubMed Abstract:
Lytic transglycosylases (LT) are enzymes involved in peptidoglycan (PG) remodeling. However, their contribution to cell-wall-modifying complexes and their potential as antimicrobial drug targets remains unclear. Here, we determined a high-resolution structure of the LT, an outer membrane lipoprotein from Neisseria species with a disordered active site helix (alpha helix 30). We show that deletion of the conserved alpha-helix 30 interferes with the integrity of the cell wall, disrupts cell division, cell separation, and impairs the fitness of the human pathogen Neisseria meningitidis during infection. Additionally, deletion of alpha-helix 30 results in hyperacetylated PG, suggesting this LtgA variant affects the function of the PG de- O- acetylase (Ape 1). Our study revealed that Ape 1 requires LtgA for optimal function, demonstrating that LTs can modulate the activity of their protein-binding partner. We show that targeting specific domains in LTs can be lethal, which opens the possibility that LTs are useful drug-targets.
Organizational Affiliation:
Unité Biologie et Génétique de la Paroi Bactérienne, Institut Pasteur; Groupe Avenir, INSERM 75015, Paris, France.
